Michael Howell
Chief Tech/Sci/R&D Officer chez ZURA BIO LIMITED
Fortune : 314 522 $ au 31/03/2024
Profil
Dr. Michael D.
Howell is a Chief Scientific Officer at Zura Bio Ltd.
Dr. Howell was previously employed as a Chief Scientific Officer by DermTech, Inc. and a Head-Translational Research by Incyte Corp.
He received his undergraduate degree from the University of Messiah and a doctorate degree from West Virginia University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZURA BIO LIMITED CLASS A
0,28% | 22/04/2024 | 122 382 ( 0,28% ) | 314 522 $ | 31/03/2024 |
Postes actifs de Michael Howell
| Sociétés | Poste | Début |
|---|---|---|
| ZURA BIO LIMITED | Chief Tech/Sci/R&D Officer | 14/04/2023 |
Anciens postes connus de Michael Howell
| Sociétés | Poste | Fin |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 01/11/2022 |
| INCYTE CORPORATION | Corporate Officer/Principal | - |
Formation de Michael Howell
| University of Messiah | Undergraduate Degree |
| West Virginia University School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| DERMTECH, INC. | Health Technology |
| ZURA BIO LIMITED | Health Technology |
